Increased de novo hepatic lipogenesis in human immunodeficiency virus infection

Marc K. Hellerstein, Carl Grunfeld, Kenneth Wu, Mark Christiansen, Suzanne Kaempfer, Cathy Kletke, Cedric H L Shackleton

Research output: Contribution to journalArticle

197 Citations (Scopus)

Abstract

We measured de novo lipogenesis in human immunodeficiency virus (HIV) infected men using a newly developed stable isotope method. HIV-infected subjects with a history of weight loss (n = 17, mean weight loss 14.9 ± 3.2 kg), asymptomatic HIV-seropositive subjects with normal CD4 T-cell counts (n = 7) and healthy HIV seronegative controls (n = 11) were studied. Hepatic lipogenesis was determined by infusion of [2-13C]-acetate, using the recently described xenobiotic probe technique with mass isotopomer analysis. Hepatic acetyl-coenzyme A enrichment was measured by high performance liquid chromatography/mass spectrometry of secreted sulfamethoxazole-acetate, with measurement of incorporation into very low density lipoproteinfatty acids by gas chromatography-mass spectrometry. Circulating tumor necrosis factor (TNF), interleukin-1 (IL-I), interferonα (IFNα), insulin, and triglycerides were measured concurrently, and 7-day weighed food records were performed. De novo hepatic lipogenesis was increased 3- to 4-fold in HIV-infected subjects with weight loss compared to normal controls (P < 0.05 for palmitate and stearate in both overnight-fasted and fed states), and was also significantly increased in asymptomatic HIV seropositive subjects. Circulating TNF and IL-1 were not measurable in any subject (detection limit 2 pg/ml for IL-1 and 20 pg/ml for TNF). Serum IFNα was measurable in 11 out of 17 subjects with wasting and correlated significantly with de novo lipogenesis in overnight-fasted but not fed states. Serum IFNα was unmeasurable in asymptomatic HIV-infected subjects despite elevated lipogenic rates. Serum triglyceride concentrations were elevated in subjects with weight loss (2.09 ± 0.28 mmol/L) and asymptomatic HIV-positives (1.34 ± 0.34 mmol/L) in comparison to controls (0.67 ± 0.08 mmol/L), and correlated with lipogenesis. Food intake correlated inversely with lipogenesis in the overnight-fasted state. We conclude that HIV infection is characterized by abnormal fat anabolism. This applies to subjects with reduced lean body mass and to asymptomatic HIV-positive subjects with normal T-cell counts. The former observation may have implications for the pathophysiology and treatment of the wasting syndrome. The latter observation is consistent with activation of the immune response and a state of viral nonlatency in early HIV disease.

Original languageEnglish (US)
Pages (from-to)559-565
Number of pages7
JournalJournal of Clinical Endocrinology and Metabolism
Volume76
Issue number3
StatePublished - Mar 1993

Fingerprint

Lipogenesis
Virus Diseases
Viruses
HIV
Liver
Weight Loss
Interleukin-1
Interferons
T-cells
Tumor Necrosis Factor-alpha
Mass spectrometry
Triglycerides
Acetates
Serum
Observation
Wasting Syndrome
T-Lymphocytes
Stearates
Sulfamethoxazole
Acetyl Coenzyme A

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Hellerstein, M. K., Grunfeld, C., Wu, K., Christiansen, M., Kaempfer, S., Kletke, C., & Shackleton, C. H. L. (1993). Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. Journal of Clinical Endocrinology and Metabolism, 76(3), 559-565.

Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. / Hellerstein, Marc K.; Grunfeld, Carl; Wu, Kenneth; Christiansen, Mark; Kaempfer, Suzanne; Kletke, Cathy; Shackleton, Cedric H L.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 76, No. 3, 03.1993, p. 559-565.

Research output: Contribution to journalArticle

Hellerstein, MK, Grunfeld, C, Wu, K, Christiansen, M, Kaempfer, S, Kletke, C & Shackleton, CHL 1993, 'Increased de novo hepatic lipogenesis in human immunodeficiency virus infection', Journal of Clinical Endocrinology and Metabolism, vol. 76, no. 3, pp. 559-565.
Hellerstein MK, Grunfeld C, Wu K, Christiansen M, Kaempfer S, Kletke C et al. Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. Journal of Clinical Endocrinology and Metabolism. 1993 Mar;76(3):559-565.
Hellerstein, Marc K. ; Grunfeld, Carl ; Wu, Kenneth ; Christiansen, Mark ; Kaempfer, Suzanne ; Kletke, Cathy ; Shackleton, Cedric H L. / Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. In: Journal of Clinical Endocrinology and Metabolism. 1993 ; Vol. 76, No. 3. pp. 559-565.
@article{25869b0476e048f480795bddfd3db26d,
title = "Increased de novo hepatic lipogenesis in human immunodeficiency virus infection",
abstract = "We measured de novo lipogenesis in human immunodeficiency virus (HIV) infected men using a newly developed stable isotope method. HIV-infected subjects with a history of weight loss (n = 17, mean weight loss 14.9 ± 3.2 kg), asymptomatic HIV-seropositive subjects with normal CD4 T-cell counts (n = 7) and healthy HIV seronegative controls (n = 11) were studied. Hepatic lipogenesis was determined by infusion of [2-13C]-acetate, using the recently described xenobiotic probe technique with mass isotopomer analysis. Hepatic acetyl-coenzyme A enrichment was measured by high performance liquid chromatography/mass spectrometry of secreted sulfamethoxazole-acetate, with measurement of incorporation into very low density lipoproteinfatty acids by gas chromatography-mass spectrometry. Circulating tumor necrosis factor (TNF), interleukin-1 (IL-I), interferonα (IFNα), insulin, and triglycerides were measured concurrently, and 7-day weighed food records were performed. De novo hepatic lipogenesis was increased 3- to 4-fold in HIV-infected subjects with weight loss compared to normal controls (P < 0.05 for palmitate and stearate in both overnight-fasted and fed states), and was also significantly increased in asymptomatic HIV seropositive subjects. Circulating TNF and IL-1 were not measurable in any subject (detection limit 2 pg/ml for IL-1 and 20 pg/ml for TNF). Serum IFNα was measurable in 11 out of 17 subjects with wasting and correlated significantly with de novo lipogenesis in overnight-fasted but not fed states. Serum IFNα was unmeasurable in asymptomatic HIV-infected subjects despite elevated lipogenic rates. Serum triglyceride concentrations were elevated in subjects with weight loss (2.09 ± 0.28 mmol/L) and asymptomatic HIV-positives (1.34 ± 0.34 mmol/L) in comparison to controls (0.67 ± 0.08 mmol/L), and correlated with lipogenesis. Food intake correlated inversely with lipogenesis in the overnight-fasted state. We conclude that HIV infection is characterized by abnormal fat anabolism. This applies to subjects with reduced lean body mass and to asymptomatic HIV-positive subjects with normal T-cell counts. The former observation may have implications for the pathophysiology and treatment of the wasting syndrome. The latter observation is consistent with activation of the immune response and a state of viral nonlatency in early HIV disease.",
author = "Hellerstein, {Marc K.} and Carl Grunfeld and Kenneth Wu and Mark Christiansen and Suzanne Kaempfer and Cathy Kletke and Shackleton, {Cedric H L}",
year = "1993",
month = "3",
language = "English (US)",
volume = "76",
pages = "559--565",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "3",

}

TY - JOUR

T1 - Increased de novo hepatic lipogenesis in human immunodeficiency virus infection

AU - Hellerstein, Marc K.

AU - Grunfeld, Carl

AU - Wu, Kenneth

AU - Christiansen, Mark

AU - Kaempfer, Suzanne

AU - Kletke, Cathy

AU - Shackleton, Cedric H L

PY - 1993/3

Y1 - 1993/3

N2 - We measured de novo lipogenesis in human immunodeficiency virus (HIV) infected men using a newly developed stable isotope method. HIV-infected subjects with a history of weight loss (n = 17, mean weight loss 14.9 ± 3.2 kg), asymptomatic HIV-seropositive subjects with normal CD4 T-cell counts (n = 7) and healthy HIV seronegative controls (n = 11) were studied. Hepatic lipogenesis was determined by infusion of [2-13C]-acetate, using the recently described xenobiotic probe technique with mass isotopomer analysis. Hepatic acetyl-coenzyme A enrichment was measured by high performance liquid chromatography/mass spectrometry of secreted sulfamethoxazole-acetate, with measurement of incorporation into very low density lipoproteinfatty acids by gas chromatography-mass spectrometry. Circulating tumor necrosis factor (TNF), interleukin-1 (IL-I), interferonα (IFNα), insulin, and triglycerides were measured concurrently, and 7-day weighed food records were performed. De novo hepatic lipogenesis was increased 3- to 4-fold in HIV-infected subjects with weight loss compared to normal controls (P < 0.05 for palmitate and stearate in both overnight-fasted and fed states), and was also significantly increased in asymptomatic HIV seropositive subjects. Circulating TNF and IL-1 were not measurable in any subject (detection limit 2 pg/ml for IL-1 and 20 pg/ml for TNF). Serum IFNα was measurable in 11 out of 17 subjects with wasting and correlated significantly with de novo lipogenesis in overnight-fasted but not fed states. Serum IFNα was unmeasurable in asymptomatic HIV-infected subjects despite elevated lipogenic rates. Serum triglyceride concentrations were elevated in subjects with weight loss (2.09 ± 0.28 mmol/L) and asymptomatic HIV-positives (1.34 ± 0.34 mmol/L) in comparison to controls (0.67 ± 0.08 mmol/L), and correlated with lipogenesis. Food intake correlated inversely with lipogenesis in the overnight-fasted state. We conclude that HIV infection is characterized by abnormal fat anabolism. This applies to subjects with reduced lean body mass and to asymptomatic HIV-positive subjects with normal T-cell counts. The former observation may have implications for the pathophysiology and treatment of the wasting syndrome. The latter observation is consistent with activation of the immune response and a state of viral nonlatency in early HIV disease.

AB - We measured de novo lipogenesis in human immunodeficiency virus (HIV) infected men using a newly developed stable isotope method. HIV-infected subjects with a history of weight loss (n = 17, mean weight loss 14.9 ± 3.2 kg), asymptomatic HIV-seropositive subjects with normal CD4 T-cell counts (n = 7) and healthy HIV seronegative controls (n = 11) were studied. Hepatic lipogenesis was determined by infusion of [2-13C]-acetate, using the recently described xenobiotic probe technique with mass isotopomer analysis. Hepatic acetyl-coenzyme A enrichment was measured by high performance liquid chromatography/mass spectrometry of secreted sulfamethoxazole-acetate, with measurement of incorporation into very low density lipoproteinfatty acids by gas chromatography-mass spectrometry. Circulating tumor necrosis factor (TNF), interleukin-1 (IL-I), interferonα (IFNα), insulin, and triglycerides were measured concurrently, and 7-day weighed food records were performed. De novo hepatic lipogenesis was increased 3- to 4-fold in HIV-infected subjects with weight loss compared to normal controls (P < 0.05 for palmitate and stearate in both overnight-fasted and fed states), and was also significantly increased in asymptomatic HIV seropositive subjects. Circulating TNF and IL-1 were not measurable in any subject (detection limit 2 pg/ml for IL-1 and 20 pg/ml for TNF). Serum IFNα was measurable in 11 out of 17 subjects with wasting and correlated significantly with de novo lipogenesis in overnight-fasted but not fed states. Serum IFNα was unmeasurable in asymptomatic HIV-infected subjects despite elevated lipogenic rates. Serum triglyceride concentrations were elevated in subjects with weight loss (2.09 ± 0.28 mmol/L) and asymptomatic HIV-positives (1.34 ± 0.34 mmol/L) in comparison to controls (0.67 ± 0.08 mmol/L), and correlated with lipogenesis. Food intake correlated inversely with lipogenesis in the overnight-fasted state. We conclude that HIV infection is characterized by abnormal fat anabolism. This applies to subjects with reduced lean body mass and to asymptomatic HIV-positive subjects with normal T-cell counts. The former observation may have implications for the pathophysiology and treatment of the wasting syndrome. The latter observation is consistent with activation of the immune response and a state of viral nonlatency in early HIV disease.

UR - http://www.scopus.com/inward/record.url?scp=0027462651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027462651&partnerID=8YFLogxK

M3 - Article

VL - 76

SP - 559

EP - 565

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 3

ER -